Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometryAdriana Pleșa, Xavier Thomas, Marie Balsat et al.|Leukemia Research|2021Cited by 7
Correlation of Clonal Hematopoiesis in Vexas Syndrome with Immunophenotype Alterations in CD34+ HSPCs (Hematopoietic Stem Progenitors Cells): Multiparametric Flow Cytometry Heterogeneity in CD34+CD38- Stem Cells Fraction and Upregulation of CD90 Thy-1 By Unsupervised Strategy Using PCA, Tsnee and FlowsomAdriana Pleșa, Maël Heiblig, Joris Gutrin et al.|Blood|2022Cited by 4